Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Authors
Keywords
-
Journal
Biomolecules
Volume 11, Issue 10, Pages 1398
Publisher
MDPI AG
Online
2021-09-23
DOI
10.3390/biom11101398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016–present)
- (2021) Aaftaab Sethi et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Pancreatic cancer stroma: an update on therapeutic targeting strategies
- (2020) Abdel N. Hosein et al. Nature Reviews Gastroenterology & Hepatology
- Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma
- (2019) Qun Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer
- (2019) Yao-Tsung Tsai et al. Molecular Therapy-Nucleic Acids
- Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
- (2018) Tsung-Chieh Shih et al. CLINICAL CANCER RESEARCH
- Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions
- (2018) Yi-Chen Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Galectins in Tumors and in Clinical Immunotherapy
- (2018) Feng-Cheng Chou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
- (2018) Carlos A. Orozco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Resistance to Immune Checkpoint Blockade
- (2018) David Liu et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Galectin–Carbohydrate Interactions in Biomedicine and Biotechnology
- (2018) Dominic Laaf et al. TRENDS IN BIOTECHNOLOGY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms
- (2016) J. M. Lykken et al. BLOOD
- Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread
- (2016) Sharad Chawla et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Galectin-1 inhibitors and their potential therapeutic applications: a patent review
- (2016) Helen Blanchard et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Impact of human galectin-1 binding to saccharide ligands on dimer dissociation kinetics and structure
- (2016) Juan M. Romero et al. GLYCOBIOLOGY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis
- (2016) Ya-Ling Hsu et al. Oncotarget
- Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma
- (2016) Gabriele Büchel et al. OncoImmunology
- Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist
- (2015) Ronald L. Schnaar JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential
- (2015) Erika M. Yazawa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Myosin IIa activation is crucial in breast cancer derived galectin-1 mediated tolerogenic dendritic cell differentiation
- (2014) Da-En Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
- (2014) N M A White et al. BRITISH JOURNAL OF CANCER
- Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
- (2014) N. Martinez-Bosch et al. CANCER RESEARCH
- Clinical relevance of galectin-1 expression in non-small cell lung cancer patients
- (2014) María José Carlini et al. LUNG CANCER
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
- (2013) Tina Verschuere et al. INTERNATIONAL JOURNAL OF CANCER
- Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer
- (2013) Ruud P. M. Dings et al. INVESTIGATIONAL NEW DRUGS
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
- (2012) L.-Y. Chung et al. CLINICAL CANCER RESEARCH
- Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin-1 and induction of poor prognosis factors
- (2012) Jaroslav Valach et al. INTERNATIONAL JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments
- (2011) Rocio Soldati et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
- (2011) Filiberto Cedeno-Laurent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
- (2010) Kimberley A. Stannard et al. CANCER LETTERS
- Galectin multimerization and lattice formation are regulated by linker region structure
- (2010) L. A. Earl et al. GLYCOBIOLOGY
- Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway
- (2010) P.-L. Kuo et al. JOURNAL OF IMMUNOLOGY
- AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
- (2008) S. J. Rodig et al. CLINICAL CANCER RESEARCH
- Immunological decision-making: how does the immune system decide to mount a helper T-cell response?
- (2007) Gerard E. Kaiko et al. IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started